Infectious olecranon and patellar bursitis: Short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 1008-1014

  Perez, Cédric ^a   Huttner, Angela ^a   Assal, Mathieu ^a   Bernard, Louis ^a,b,c   Lew, Daniel ^a   Hoffmeyer, Pierre ^a   Uçkay, Ilker ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Bursectomy; Parenteral; Septic bursitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CLINDAMYCIN; FLUCLOXACILLIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BURSECTOMY; BURSITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE SEVERITY; ELBOW; ENTEROCOCCUS FAECALIS; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL PATIENT; HUMAN; IMMUNE DEFICIENCY; KLEBSIELLA OXYTOCA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OLECRANON; PATELLA; RECURRENCE RISK; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME; AGED; BACTERIUM; CLASSIFICATION; HOSPITALIZATION; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RISK FACTOR; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BURSITIS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OLECRANON PROCESS; PATELLA; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953702880     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq043     Document Type: Article

References (22)

1. Cea-Pereiro JC, Garcia-Meijide J, Mera-Varela A et al. A comparison between septic bursitis caused by Staphylococcus aureus and those caused by other organisms. Clin Rheumatol 2001; 20: 10-4.
2. Söderquist B, Hedström SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis 1986; 18: 305-11.
3. Garcia-Porrua C, Gonzalez-Gay MA, Ibaňez D et al. The clinical spectrum of severe septic bursitis in northwestern Spain: a 10 year study. J Rheumatol 1999; 26: 663-7.
4. Hoffmeyer P, Chalmers A, Price GE. Septic olecranon bursitis in a general hospital population. Can Med Assoc J 1980; 122: 874-6.
5. Ho G Jr, Tice AD, Kaplan SR. Septic bursitis in the prepatellar and olecranon bursae: an analysis of 25 cases. Ann Intern Med 1978; 89: 21-7.
6. Canoso JJ, Sheckman PR. Septic subcutaneous bursitis. Report of sixteen cases. J Rheumatol 1979; 6: 96-102.
7. Knight JM, Thomas JC, Maurer RC. Treatment of septic olecranon and prepatellar bursitis with percutaneous placement of a suction-irrigation system: a report of 12 cases. Clin Orthop Relat Res 1986; 206: 90-3.
8. Ho G Jr, Su EY. Antibiotic therapy of septic bursitis. Its implication in the treatment of septic arthritis. Arthritis Rheum 1981; 24: 905-11.
9. Roschmann RA, Bell CL. Septic bursitis in immunocompromised patients. Am J Med 1987; 83: 661-5.
10. Stell IM. Management of acute bursitis: outcome study of a structured approach. J R Soc Med 1999; 92: 516-21.
11. Laupland KB, Davies HD; for the Calgary Home Parenteral Therapy Program Study Group. Olecranon septic bursitis managed in an ambulatory setting. Clin Invest Med 2001; 24:171-8.
12. Wasserman AR, Melville LD, Birkhahn RH. Septic bursitis: a case report and primer for the emergency clinician. J Emerg Med 2007; 33: 100-4.
13. Zimmermann B III, Mikolich DJ, Ho G Jr. Septic bursitis. Semin Arthritis Rheum 1995; 24: 391-410.
14. Smith JW, Shahbaz HM. Bone and joint infections. Infectious arthritis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Fifth Edition. Philadelphia, PA: Churchill Livingstone, 2000; 1181-5.
15. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2001; 22: 222-42.
16. Uçkay I, Vernaz-Hegi N, Harbarth S et al. Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect 2009; 58: 205-12.
17. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-83.
18. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007; 165: 710-8.
19. Pien FD, Ching D, Kim E. Septic bursitis: experience in a community practice. Orthopedics 1991; 14: 981-4.
20. Raddatz DA, Hoffman GS, Franck WA. Septic bursitis: presentation, treatment and prognosis. J Rheumatol. 1987; 14: 1160-3.
21. Young MH, Aronoff DM, Engleberg NC. Necrotizing fasciitis: pathogenesis and treatment. Expert Rev Anti Infect Ther 2005; 3: 279-94.
22. Sheon RP, Kotton CN. Septic bursitis. UpToDateTM (software) 2009; Version 1.1.2009